Cargando…
A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19
The Seraph100 Microbind Affinity Blood Filter (Seraph 100) (ExThera Medical, Martinez, CA) is an extracorporeal therapy that can remove pathogens from blood, including severe acute respiratory syndrome coronavirus 2. The aim of this study was to evaluate safety and efficacy of Seraph 100 treatment f...
Autores principales: | Chitty, Stephen A., Mobbs, Sarah, Rifkin, Brian S., Stogner, Steven W., Lewis, Michael S., Betancourt, Jaime, DellaVolpe, Jeffrey, Abouzahr, Fadi, Wilhelm, Andrew M., Szerlip, Harold M., Parikh, Amay, Gaeta, Robert M., Rivera, Ian, Park, Caroline, Levi, Benjamin, Anesi, George L., Alcover, Karl C., Arnold, Thomas B., Howard, Jeffrey T., Sharma, Kumar, Pratt, Kathleen P., Stewart, Ian J., Chung, Kevin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049035/ https://www.ncbi.nlm.nih.gov/pubmed/35506015 http://dx.doi.org/10.1097/CCE.0000000000000662 |
Ejemplares similares
-
In vitro elimination of anti-infective drugs by the Seraph(®) 100 Microbind(®) affinity blood filter
por: Schmidt, Julius J, et al.
Publicado: (2020) -
Treatment of a Critically Ill COVID-19 Patient with the Seraph 100 Microbind Affinity Filter
por: Pape, Anke, et al.
Publicado: (2021) -
Interim analysis of the COSA (COVID-19 patients treated with the Seraph(®) 100 Microbind(®) Affinity filter) registry
por: Schmidt, Julius J, et al.
Publicado: (2021) -
Staphylococcus aureus binding to Seraph(®) 100 Microbind(®) Affinity Filter: Effects of surface protein expression and treatment duration
por: Seffer, Malin-Theres, et al.
Publicado: (2023) -
Safety and efficacy of the Seraph® 100 Microbind® Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study
por: Eden, Gabriele, et al.
Publicado: (2022)